Skip to main content

Dr. Joseph M. Tuscano, M.D.

Hematology & Oncology (Hematology & Oncology Physician)

  • Medicare participating

At a glance

Years since graduation
37
In the NPI registry since
2005
Medicare patients seen, 2024
272

Licensed in California since 1990, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1989Medical school: University of Southern California Keck School of Medicine
  • 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Hematology & Oncology Physician primary
    CA license G69025 (first issued 1990; current) · CA license G069025 (first issued 1990; current)
  • Specialist
    CA license G069025 (first issued 1990; current)

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Hematology & Oncology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
272
Services billed
1,452
Patients’ average age
73
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 40-54 minutes520196
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes17025
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes11025
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or5339
New patient office or other outpatient visit, 60-74 minutes3535
Established patient office or other outpatient visit, 30-39 minutes3127
Telephone medical discussion with physician, 21-30 minutes3022
Established patient office or other outpatient visit, 20-29 minutes1614

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Brukinsa (zanubrutinib)75
Imbruvica (ibrutinib)38
Acyclovir
Other prescribers in Sacramento, CA
29
Ondansetron Hcl
Other prescribers in Sacramento, CA
24
Posaconazole20
Prochlorperazine Maleate
Other prescribers in Sacramento, CA
13
Inrebic (fedratinib dihydrochloride)11

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 3 companies reported 3 payments worth $201 in total to this clinician.

By company
Janssen Biotech, Inc.$122
Acrotech Biopharma Inc.$44.79
Celgene Corporation$34.34
By type
Food and Beverage$201

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in California →

Industry-funded research

Named as a principal investigator on 9 industry-funded studies in 2025, from 7 companies. The companies reported $3,120,753 in research payments for these studies, mostly to the institutions running them.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Hematology & Oncology clinicians in Sacramento

Sources

NPI registry (CMS NPPES, November 2026; record last updated August 30, 2019), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1487639795. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.